Literature DB >> 10631574

Stage differentiation of the protozoan parasite Toxoplasma gondii.

W Bohne1, M Holpert, U Gross.   

Abstract

The obligate intracellular parasite Toxoplasma gondii is able to persist lifelong in its hosts by differentiating from the replicative tachyzoite stage into cyst forming latent bradyzoites. Beside the clinical relevance of stage conversion and its importance for pathogenesis and prevention of toxoplasmic encephalitis, reversible stage differentiation in T. gondii is an interesting model system of protozoan differentiation in general. In recent years a variety of molecular techniques have been developed for T. gondii, including transfection systems and the development of many selectable markers. Together with tissue culture models in which stage differentiation from tachyzoites to bradyzoites can be induced these techniques provide the tools for a molecular dissection of the differentiation pathways. Three aspects of stage conversion are highlighted in this review, including the alteration of the parasite surface, alterations in parasite metabolism and the induction of genes associated with stress response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631574     DOI: 10.1016/S0171-2985(99)80065-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  16 in total

1.  In vitro induction of Neospora caninum bradyzoites in vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites.

Authors:  Nathalie Vonlaufen; Nicole Guetg; Arunasalam Naguleswaran; Norbert Müller; Camilla Björkman; Gereon Schares; Daniela von Blumroeder; John Ellis; Andrew Hemphill
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 2.  Subversion of innate and adaptive immune responses by Toxoplasma gondii.

Authors:  Christine Lang; Uwe Gross; Carsten G K Lüder
Journal:  Parasitol Res       Date:  2006-10-06       Impact factor: 2.289

3.  Detection of murine toxoplasmosis using magnetic bead-based serum peptide profiling by MALDI-TOF MS.

Authors:  Jiping Li; Hongtao Jin; Lixia Li; Limin Shang; Yongkun Zhao; Feng Wei; Yanjing Liu; Quan Liu; Jun Qian
Journal:  Vector Borne Zoonotic Dis       Date:  2012-03-26       Impact factor: 2.133

4.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

5.  A Purification Method for Enrichment of the Toxoplasma gondii Cyst Wall.

Authors:  Yi Wei Zhang; Sandra K Halonen; Yan Fen Ma; Herbert B Tanowtiz; Louis M Weiss
Journal:  J Neuroparasitology       Date:  2010-12

6.  Integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses.

Authors:  Lucia Peixoto; Feng Chen; Omar S Harb; Paul H Davis; Daniel P Beiting; Catie Small Brownback; Dinkorma Ouloguem; David S Roos
Journal:  Cell Host Microbe       Date:  2010-08-19       Impact factor: 21.023

7.  Initial characterization of CST1, a Toxoplasma gondii cyst wall glycoprotein.

Authors:  Y W Zhang; S K Halonen; Y F Ma; M Wittner; L M Weiss
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  Identification and characterisation of a regulatory region in the Toxoplasma gondii hsp70 genomic locus.

Authors:  Yan Fen Ma; YiWei Zhang; Kami Kim; Louis M Weiss
Journal:  Int J Parasitol       Date:  2004-03-09       Impact factor: 3.981

9.  The differential protein expression profiles and immunogenicity of tachyzoites and bradyzoites of in vitro cultured Neospora caninum.

Authors:  Seung-Won Kang; Eun-Hang Lee; Young-Hwa Jean; Se-Eun Choe; Dong Van Quyen; Myeong-Sok Lee
Journal:  Parasitol Res       Date:  2008-07-03       Impact factor: 2.289

10.  Possible role of Toxoplasma gondii in brain cancer through modulation of host microRNAs.

Authors:  Sivasakthivel Thirugnanam; Namita Rout; Munirathinam Gnanasekar
Journal:  Infect Agent Cancer       Date:  2013-02-08       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.